Latest biotechnology Stories
LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...
LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...
WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Scientists in Oregon announced today that they had created cloned human embryos, and then destroyed the embryos to extract embryonic stem cells. The cloning technique is essentially the same one used to create Dolly the cloned sheep, with some modifications to make cloning work using human eggs and human cells. This is the first claim of growing human embryonic stem cells from cloned human embryos since the fraudulent claims in...
USCCB Pro-Life Chair Responds to Cloning Breakthrough in Oregon Says Creating Embryos To Destroy Them Objectionable to Non-Catholics Too Notes That Morally Acceptable Scientific Advances Already Addressing Same Goals WASHINGTON, May 15, 2013 /PRNewswire-USNewswire/ -- Human cloning for any purpose is inconsistent with the moral responsibility to "treat each member of the human family as a unique gift of God, as a person with his or her own inherent dignity," said the chairman of...
Edgemont enhances its position as the leading M&A advisor to clinical research site companies NEW YORK, May 15, 2013 /PRNewswire/ -- Edgemont Capital Partners ("Edgemont"), a specialty investment bank focused on the merger and acquisition advisory needs of healthcare companies, has acted as exclusive financial advisor to Vince and Associates Clinical Research ("Vince and Associates") in its sale to Altasciences Group. Vince and Associates manages complex early development clinical...
SAN RAMON, Calif., May 15, 2013 /PRNewswire-USNewswire/ -- The Center for Bioethics and Culture strongly decries the practice of deriving human embryonic stem cells through cloning because it exploits women for their eggs, it commodifies human life, and it is unnecessary. In the June 6, 2013, issue of the scientific journal Cell, researchers announce that they have successfully derived human embryonic stem cells through somatic cell nuclear transfer (SCNT) cloning. The authors of the...
Researchers use synthetic silicate to stimulate stem cells into bone cells In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital (BWH) are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors. Synthetic silicates are made up of simple or complex salts of silicic acids, and have been used extensively...
Organ Regeneration Noted As Top Priority in 2013 US Presidential State of the Union Address LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology...
LOS ANGELES, May 15, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage biotechnology company focused on developing innovative targeted immunotherapies for cancer, today announced that it has closed a $20 million private placement of shares of its Series A Preferred Stock. In addition to the $20 million in new funds, Kite converted $15 million in outstanding promissory notes into shares of Series A Preferred Stock. Joined by a new investor, Alta Partners, all existing...
Collaboration connects gene expression data and physiological mechanistic model simulations that should illuminate best treatment for selected patients. San Mateo, CA (PRWEB) May 14, 2013 Entelos Holding Corp. (“Entelos” or “the Company”), a premier provider of physiological system modeling and services, and Seattle-based Institute for System Biology (ISB), the nonprofit pioneers of the systems approach to study the molecular causes of diseases, today announced the successful...
Latest biotechnology Reference Libraries
Biotechnology and Applied Biochemistry is a peer-reviewed academic journal established in 1979 under the title Journal of Applied Biochemistry and published by Academic Press. It assumed its present title in 1986 and publication was taken over by Portland Press in 1993. It is now published bimonthly by Wiley-Blackwell (since 2011). It is the official journal of the International Union of Biochemistry and Molecular Biology. The journal publishes scholarly Articles and Reviews relating to...
Cell is a peer-reviewed scientific journal founded by Benjamin Lewin in January 1974 with the sponsorship of MIT Press. Lewin bought the rights to the journal in 1986 and published it under his own publishing arm Cell Press. Cell Press was sold to Elsevier in 1999, which currently publishes Cell twice monthly. Cell Press publishes several biomedical journals, including Cell, Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry &...
Agrobacterium tumefaciens is the causal agent of crown gall disease (the formation of tumours) in over 140 species of dicot. It is rod shaped. Symptoms are caused by the insertion of a small segment of DNA into the plant cell. It is an alphaproteobacterium of the family Rhizobiaceae which includes the nitrogen fixing legume symbionts. They are pathogenic and provide no benefit to the plant. It also affects a wide variety of plants. In an economical sense it affects walnuts, grape vines,...
